Logo image of HUN

HUNTSMAN CORP (HUN) Stock Fundamental Analysis

NYSE:HUN - New York Stock Exchange, Inc. - US4470111075 - Common Stock - Currency: USD

11.11  -0.21 (-1.86%)

After market: 11.15 +0.04 (+0.36%)

Fundamental Rating

3

HUN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. HUN may be in some trouble as it scores bad on both profitability and health. HUN is valued expensive and it does not seem to be growing. Finally HUN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HUN has reported negative net income.
In the past year HUN had a positive cash flow from operations.
HUN had positive earnings in 4 of the past 5 years.
In the past 5 years HUN always reported a positive cash flow from operatings.
HUN Yearly Net Income VS EBIT VS OCF VS FCFHUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

HUN's Return On Assets of -2.17% is on the low side compared to the rest of the industry. HUN is outperformed by 67.06% of its industry peers.
HUN has a Return On Equity of -5.37%. This is in the lower half of the industry: HUN underperforms 65.88% of its industry peers.
The Return On Invested Capital of HUN (1.19%) is worse than 74.12% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HUN is below the industry average of 6.84%.
Industry RankSector Rank
ROA -2.17%
ROE -5.37%
ROIC 1.19%
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
HUN Yearly ROA, ROE, ROICHUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

HUN has a Operating Margin of 1.44%. This is in the lower half of the industry: HUN underperforms 76.47% of its industry peers.
HUN's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 14.49%, HUN is doing worse than 72.94% of the companies in the same industry.
In the last couple of years the Gross Margin of HUN has declined.
Industry RankSector Rank
OM 1.44%
PM (TTM) N/A
GM 14.49%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
HUN Yearly Profit, Operating, Gross MarginsHUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

2

2. Health

2.1 Basic Checks

HUN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for HUN has been increased compared to 1 year ago.
The number of shares outstanding for HUN has been reduced compared to 5 years ago.
HUN has a worse debt/assets ratio than last year.
HUN Yearly Shares OutstandingHUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HUN Yearly Total Debt VS Total AssetsHUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

HUN has an Altman-Z score of 1.68. This is a bad value and indicates that HUN is not financially healthy and even has some risk of bankruptcy.
HUN has a Altman-Z score (1.68) which is comparable to the rest of the industry.
HUN has a debt to FCF ratio of 25.71. This is a negative value and a sign of low solvency as HUN would need 25.71 years to pay back of all of its debts.
With a Debt to FCF ratio value of 25.71, HUN perfoms like the industry average, outperforming 44.71% of the companies in the same industry.
HUN has a Debt/Equity ratio of 0.57. This is a neutral value indicating HUN is somewhat dependend on debt financing.
HUN has a Debt to Equity ratio (0.57) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 25.71
Altman-Z 1.68
ROIC/WACC0.15
WACC8.01%
HUN Yearly LT Debt VS Equity VS FCFHUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

HUN has a Current Ratio of 1.48. This is a normal value and indicates that HUN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.48, HUN is not doing good in the industry: 68.24% of the companies in the same industry are doing better.
HUN has a Quick Ratio of 1.48. This is a bad value and indicates that HUN is not financially healthy enough and could expect problems in meeting its short term obligations.
HUN's Quick ratio of 0.82 is on the low side compared to the rest of the industry. HUN is outperformed by 77.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 0.82
HUN Yearly Current Assets VS Current LiabilitesHUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

3

3. Growth

3.1 Past

HUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -220.00%.
The Revenue has been growing slightly by 0.02% in the past year.
The Revenue has been decreasing by -2.35% on average over the past years.
EPS 1Y (TTM)-220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.33%
Revenue 1Y (TTM)0.02%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%-4.08%

3.2 Future

HUN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 143.43% yearly.
HUN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.54% yearly.
EPS Next Y-450.45%
EPS Next 2Y138.41%
EPS Next 3Y143.43%
EPS Next 5YN/A
Revenue Next Year-1.4%
Revenue Next 2Y1.8%
Revenue Next 3Y2.54%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HUN Yearly Revenue VS EstimatesHUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
HUN Yearly EPS VS EstimatesHUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HUN. In the last year negative earnings were reported.
HUN is valuated quite expensively with a Price/Forward Earnings ratio of 43.08.
HUN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. HUN is more expensive than 69.41% of the companies in the same industry.
HUN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.89.
Industry RankSector Rank
PE N/A
Fwd PE 43.08
HUN Price Earnings VS Forward Price EarningsHUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60 -80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HUN is valued a bit cheaper than 63.53% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, HUN is valued a bit cheaper than the industry average as 64.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 25.4
EV/EBITDA 9.47
HUN Per share dataHUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

HUN's earnings are expected to grow with 143.43% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y138.41%
EPS Next 3Y143.43%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.00%, HUN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.57, HUN pays a better dividend. On top of this HUN pays more dividend than 94.12% of the companies listed in the same industry.
HUN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 9%

5.2 History

On average, the dividend of HUN grows each year by 9.05%, which is quite nice.
HUN has paid a dividend for at least 10 years, which is a reliable track record.
HUN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.05%
Div Incr Years4
Div Non Decr Years17
HUN Yearly Dividends per shareHUN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

HUN has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of HUN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-110.83%
EPS Next 2Y138.41%
EPS Next 3Y143.43%
HUN Yearly Income VS Free CF VS DividendHUN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

HUNTSMAN CORP

NYSE:HUN (7/3/2025, 7:34:37 PM)

After market: 11.15 +0.04 (+0.36%)

11.11

-0.21 (-1.86%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-01 2025-05-01/amc
Earnings (Next)07-31 2025-07-31/bmo
Inst Owners89.13%
Inst Owner Change-50.93%
Ins Owners5.31%
Ins Owner Change4.6%
Market Cap1.93B
Analysts64.76
Price Target14.36 (29.25%)
Short Float %5.1%
Short Ratio2.1
Dividend
Industry RankSector Rank
Dividend Yield 9%
Yearly Dividend1.01
Dividend Growth(5Y)9.05%
DP-110.83%
Div Incr Years4
Div Non Decr Years17
Ex-Date06-13 2025-06-13 (0.25)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-76.47%
Min EPS beat(2)-152.09%
Max EPS beat(2)-0.84%
EPS beat(4)1
Avg EPS beat(4)-37.63%
Min EPS beat(4)-152.09%
Max EPS beat(4)4.35%
EPS beat(8)1
Avg EPS beat(8)-27.85%
EPS beat(12)3
Avg EPS beat(12)-20.94%
EPS beat(16)7
Avg EPS beat(16)-13.35%
Revenue beat(2)0
Avg Revenue beat(2)-3.33%
Min Revenue beat(2)-6.25%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-2.91%
Min Revenue beat(4)-6.25%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-2.39%
Revenue beat(12)2
Avg Revenue beat(12)-2.31%
Revenue beat(16)3
Avg Revenue beat(16)-3.03%
PT rev (1m)-2.66%
PT rev (3m)-30.15%
EPS NQ rev (1m)-5.24%
EPS NQ rev (3m)-233.72%
EPS NY rev (1m)-62.02%
EPS NY rev (3m)-447.2%
Revenue NQ rev (1m)-0.07%
Revenue NQ rev (3m)-7.71%
Revenue NY rev (1m)-0.17%
Revenue NY rev (3m)-5.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 43.08
P/S 0.32
P/FCF 25.4
P/OCF 7.6
P/B 0.66
P/tB 0.99
EV/EBITDA 9.47
EPS(TTM)-0.12
EYN/A
EPS(NY)0.26
Fwd EY2.32%
FCF(TTM)0.44
FCFY3.94%
OCF(TTM)1.46
OCFY13.16%
SpS34.39
BVpS16.83
TBVpS11.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.17%
ROE -5.37%
ROCE 1.51%
ROIC 1.19%
ROICexc 1.27%
ROICexgc 1.55%
OM 1.44%
PM (TTM) N/A
GM 14.49%
FCFM 1.27%
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
ROICexc(3y)4.26%
ROICexc(5y)5.51%
ROICexgc(3y)5.21%
ROICexgc(5y)6.86%
ROCE(3y)4.87%
ROCE(5y)5.65%
ROICexcg growth 3Y-54.19%
ROICexcg growth 5Y-26.52%
ROICexc growth 3Y-53.71%
ROICexc growth 5Y-28.3%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
F-Score5
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 25.71
Debt/EBITDA 4.45
Cap/Depr 61.59%
Cap/Sales 2.98%
Interest Coverage 1.18
Cash Conversion 67.73%
Profit Quality N/A
Current Ratio 1.48
Quick Ratio 0.82
Altman-Z 1.68
F-Score5
WACC8.01%
ROIC/WACC0.15
Cap/Depr(3y)81.07%
Cap/Depr(5y)89.35%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-83.33%
EPS Next Y-450.45%
EPS Next 2Y138.41%
EPS Next 3Y143.43%
EPS Next 5YN/A
Revenue 1Y (TTM)0.02%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%-4.08%
Revenue Next Year-1.4%
Revenue Next 2Y1.8%
Revenue Next 3Y2.54%
Revenue Next 5YN/A
EBIT growth 1Y115%
EBIT growth 3Y-53.86%
EBIT growth 5Y-29.79%
EBIT Next Year154.68%
EBIT Next 3Y67.52%
EBIT Next 5YN/A
FCF growth 1Y-82.16%
FCF growth 3Y-49.41%
FCF growth 5Y-33.84%
OCF growth 1Y-62.37%
OCF growth 3Y-34.87%
OCF growth 5Y-21.76%